Nanosonics LimitedASX: NAN

2026 Investor Presentation

· Issued by Nanosonics Limited via ASX

Filed with ASX ·

Draft v4 FY26 Investor Presentation 25 August 2026 Infection prevention. For life. Michael Kavanagh CEO & President Jason Burriss CFO Protecting 31 million patients every year Nanosonics develops transformative technologies in medical device reprocessing to improve patient...

View Attachment

6ix hasn’t read this filing yet.

Nanosonics Limited on 6ix

In the deck

Earlier from Nanosonics

Later from Nanosonics

All Nanosonics news releases